Abstract: The Economic Impact of Skin Cancer

RESULTS: Fifty-five participants (31 patients and 24 parents) completed all questionnaires, 98.2% preferred active involvement in therapeutic decision-making. The SDM-Q-9 scores, assessed by patients and physicians, were acceptable (mean 68 out of 100). However, the independently assessed OPTION-5 scores were significantly lower (mean 31 out of 100). In the consultations, physicians rarely asked for patient preferences regarding involvement. In addition, the patient’s freedom of choice and pros and cons of treatment options were inadequately explained. The degree of patient involvement from the patient’s perspective (CollaboRATE) was significantly correlated with patient satisfaction (ρ 0.35, p<0.01).